This product can measure the SARS-CoV-2 spike protein in samples.
Features of the kit: - It is possible to measure SARS-CoV-2 spike protein in samples such as serum and plasma. - No special equipment is required; measurements can be taken with a standard plate reader. - Using a sandwich ELISA method with two types of antibodies against the RBD of the SARS-CoV-2 S1 domain, it sensitively and specifically measures the SARS-CoV-2 spike protein. - The antibodies used in this ELISA strongly react with all variants of the virus, including the Wuhan strain, as well as Alpha, Beta, Gamma, and Delta variants (manuscript in preparation).
Inquire About This Product
basic information
Contents 1. Anti-SARS-CoV-2 spike protein antibody solid-phase plate, 96 wells (8 wells x 12 strips), 1 piece 2. Standard protein, 200μL (25,000pg/mL), 1 vial 3. Assay buffer, 25mL, 1 vial 4. Washing buffer (10x concentrated), 25mL, 1 vial 5. HRP-labeled anti-SARS-CoV-2 spike protein antibody (500x concentrated), 20μL, 1 vial 6. Substrate solution, 12mL, 1 vial 7. Stop solution (2N H2SO4), 6mL, 1 vial
Price range
P2
Delivery Time
P3
Applications/Examples of results
Species origin: Human Application: Enzyme Linked Immunosorbent Assay Measurement range: 39.1–2500 pg/mL Purpose of use: This product can measure SARS-CoV-2 spike protein in samples using a sandwich ELISA method with two types of neutralizing antibodies that are specific and have high affinity for the RBD of the spike protein S1 domain.
Line up（1）
| Model number | overview |
|---|---|
| HAK-HELSRBD-1 | SARS-CoV-2 Spike Glycoprotein ELISA Kit |
Company information
Hakarel Co., Ltd. primarily supports research on exosome detection methods and offers contract services such as the production of recombinant proteins, the creation of monoclonal antibodies, the establishment of ELISA measurement systems, exosome ELISA measurements, and proteomics analysis. We respond flexibly to customer requests and provide support for research and development. Please feel free to contact us if you have any inquiries.
